Novel Inflammatory Biomarkers in Cardiovascular Therapeutics
- PMID: 25921646
- DOI: 10.2174/0929867322666150429110124
Novel Inflammatory Biomarkers in Cardiovascular Therapeutics
Abstract
Inflammation has been established as an important determinant of cardiovascular disease progression. Currently, clinical examination, laboratory and imaging tests are invaluable for the diagnosis, prognosis and disease monitoring. Novel inflammatory biomarkers are also used to better restratify patients in risk groups but their potential to guide treatment decisions and management of patients has not been extensively evaluated. Therefore, in this review article we present the most recent data concerning the use of inflammatory biomarkers in cardiovascular therapeutics.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources